Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP)
Clinical trial NCT04076683 · COMPLETED
Trial details
- NCT number
- NCT04076683
- Sponsor
- Etablissement Français du Sang
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2023-11-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.